Permeapad™ for investigation of passive drug permeability: The effect of surfactants, co-solvents and simulated intestinal fluids (FaSSIF and FeSSIF)

被引:43
作者
Bibi, Hanady Ajine [1 ]
di Cagno, Massimiliano [2 ]
Holm, Rene [3 ]
Bauer-Brandl, Annette [1 ]
机构
[1] Univ Southern Denmark, Dept Phys Chem & Pharm, DK-5230 Odense, Denmark
[2] UiT, Dept Pharm, Drug Transport & Delivery Res Grp, N-9037 Tromso, Norway
[3] H Lundbeck & Co AS, Biol & Pharmaceut Sci, DK-2500 Valby, Denmark
关键词
Apparent permeability; Permeapad (TM); FaSSIF; FeSSIF; Surfactants; Co-solvents; CACO-2 CELL MONOLAYERS; IN-VITRO PERMEABILITY; VESICLE-BASED BARRIER; WATER-SOLUBLE DRUGS; PERMEATION ASSAY; DISSOLUTION MEDIA; ABSORPTION; CLASSIFICATION; SYSTEM; PAMPA;
D O I
10.1016/j.ijpharm.2015.07.028
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of the present work was to investigate the potential of the new and innovative artificial barrier, Permeapad (TM), when exposed to surfactants and co-solvents, often employed for poorly water soluble compounds. The barrier was in addition also exposed to fasted and fed state simulated intestinal fluids versions 1 and 2 (FaSSIF and FeSSIF), all of which the Permeapad (TM) barrier was compatible with based upon relative comparison of the permeability of the hydrophilic marker calcein in phosphate buffer. The new barrier therefore holds a huge potential due to its functional stability and robustness. It can be used as a standard tool to investigate permeability of drugs in the presence of different surfactants and co-solvents, from DMSO stock solutions at even high concentrations and for the evaluation of permeability in the presence of biomimetic media (BMM).(1) (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:192 / 197
页数:6
相关论文
共 25 条
[1]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[2]  
Avdeef Alex, 2005, Expert Opin Drug Metab Toxicol, V1, P325, DOI 10.1517/17425255.1.2.325
[3]  
Bauer-Brandl A., 2014, Danish Patent Application, Patent No. [PA 2014 70708, 201470708]
[4]   IVIVC for Fenofibrate Immediate Release Tablets Using Solubility and Permeability as In Vitro Predictors for Pharmacokinetics [J].
Buch, Philipp ;
Holm, Per ;
Thomassen, Jesper Qvist ;
Scherer, Dieter ;
Branscheid, Robert ;
Kolb, Ute ;
Langguth, Peter .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 99 (10) :4427-4436
[5]   In vitro models to evaluate the permeability of poorly soluble drug entities: Challenges and perspectives [J].
Buckley, Stephen T. ;
Fischer, Sarah M. ;
Fricker, Gert ;
Brandl, Martin .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 45 (03) :235-250
[6]   New biomimetic barrier Permeapad™ for efficient investigation of passive permeability of drugs [J].
di Cagno, Massimiliano ;
Bibi, Hanady A. ;
Bauer-Brandl, Annette .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 73 :29-34
[7]   In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs [J].
Dressman, JB ;
Reppas, C .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 11 :S73-S80
[8]   Dissolution testing as a prognostic tool for oral drug absorption: Immediate release dosage forms [J].
Dressman, JB ;
Amidon, GL ;
Reppas, C ;
Shah, VP .
PHARMACEUTICAL RESEARCH, 1998, 15 (01) :11-22
[9]   Effect of the non-ionic surfactant Poloxamer 188 on passive permeability of poorly soluble drugs across Caco-2 cell monolayers [J].
Fischer, Sarah Maud ;
Brandl, Martin ;
Fricker, Gert .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2011, 79 (02) :416-422
[10]   In-vitro permeability of poorly water soluble drugs in the phospholipid vesicle-based permeation assay: the influence of nonionic surfactants [J].
Fischer, Sarah Maud ;
Flaten, Goril Eide ;
Hagesaether, Ellen ;
Fricker, Gert ;
Brandl, Martin .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2011, 63 (08) :1022-1030